Articles tagged with Hepatocyte Growth Factor
A new study found that MET signaling plays a critical protective role in acetaminophen-induced acute liver failure by reducing liver damage and accelerating regeneration. The findings suggest targeting MET signaling could become a game-changer for treating drug-induced ALF, potentially reducing the need for emergency liver transplants.
Researchers from Kyushu University have developed an antibody that targets and prevents the dysfunction of hepatocyte growth factor (HGF), a critical protein for skeletal muscle development, regeneration, and repair. The new antibody, 1H42F4N, blocked nitration of HGF and did not disrupt its activity.
Researchers found that gene therapy approach and small molecule treatment can calm the destructive cells of ALS by preserving upper motor neurons. Improving mitochondrial health also reduces astrocyte attack on diseased neurons, offering new hope for treating ALS.
A substance in human mesenchymal stem cells promotes nerve restoration and myelin sheath repair in rodent models of multiple sclerosis. Hepatocyte growth factor, a key instigator, decreases inflammation and increases signaling molecules counteracting it, leading to neural cell growth and nerve rewinding.
Research on plasminogen-related growth factors has shed light on their role in mammalian development, tumorigenesis, and angiogenesis. The symposium explores the evolution of these growth factors and their interactions with other molecules, highlighting their importance in various biological processes.